Sale!

SPTAN1 Gene Early Infantile Epileptic Encephalopathy Type 5 Genetic Test

Original price was: $700.Current price is: $500.

-29%

The SPTAN1 Gene Early Infantile Epileptic Encephalopathy Type 5 NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the SPTAN1 gene associated with severe neurological conditions in infants. This comprehensive test utilizes next-generation sequencing technology to detect specific genetic variants responsible for early-onset epileptic encephalopathy type 5. The test is crucial for infants presenting with developmental delays, seizures, and neurological abnormalities, providing essential information for accurate diagnosis and personalized treatment strategies. Results are typically available within 3-4 weeks, and the test requires either blood sample, extracted DNA, or a single drop of blood on an FTA card. The discounted price for this vital genetic screening is $500 USD, offering families affordable access to advanced neurological genetic testing.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

SPTAN1 Gene Early Infantile Epileptic Encephalopathy Type 5 NGS Genetic DNA Test

Comprehensive Genetic Testing for Severe Neurological Disorders

The SPTAN1 Gene Early Infantile Epileptic Encephalopathy Type 5 NGS Genetic DNA Test represents a breakthrough in pediatric neurological diagnostics. This advanced genetic screening targets mutations in the SPTAN1 gene, which encodes alpha-II spectrin, a crucial structural protein essential for maintaining neuronal integrity and proper brain development. Early infantile epileptic encephalopathy type 5 is a severe neurological condition characterized by treatment-resistant seizures, developmental regression, and significant cognitive impairment that typically manifests within the first months of life.

What Does This Test Measure?

This sophisticated genetic analysis employs next-generation sequencing (NGS) technology to comprehensively examine the SPTAN1 gene for pathogenic variants. The test specifically detects:

  • Point mutations and single nucleotide variants affecting gene function
  • Small insertions and deletions that disrupt protein structure
  • Copy number variations impacting gene dosage
  • Structural rearrangements affecting spectrin protein formation
  • De novo mutations that may not be present in parental DNA

Who Should Consider This Test?

This specialized genetic test is recommended for infants and young children presenting with specific clinical features, including:

  • Early-onset seizures within the first 6 months of life
  • Developmental regression or stagnation
  • Hypotonia (reduced muscle tone) progressing to spasticity
  • Microcephaly or abnormal head growth patterns
  • Abnormal EEG patterns consistent with epileptic encephalopathy
  • Family history of similar neurological conditions
  • Unexplained developmental delays with seizure activity

Clinical Benefits of Genetic Testing

Undergoing the SPTAN1 gene test provides numerous advantages for affected families and healthcare providers:

  • Accurate Diagnosis: Confirms or rules out SPTAN1-related disorders with high precision
  • Personalized Treatment: Enables targeted therapeutic approaches based on genetic findings
  • Prognostic Information: Provides insights into disease progression and expected outcomes
  • Family Planning: Offers crucial information for genetic counseling and reproductive decisions
  • Clinical Trial Eligibility: May qualify patients for specialized treatment protocols
  • Early Intervention: Facilitates timely implementation of supportive therapies

Understanding Your Test Results

Our comprehensive genetic counseling team will help you interpret your results with clarity and compassion:

  • Positive Result: Indicates the presence of a pathogenic SPTAN1 mutation, confirming the diagnosis of early infantile epileptic encephalopathy type 5
  • Negative Result: Suggests that SPTAN1 mutations are not the cause of the clinical symptoms, guiding further diagnostic evaluation
  • Variant of Uncertain Significance: Identifies genetic changes whose clinical impact requires additional research and family studies
  • Carrier Status: May reveal important information about inheritance patterns and recurrence risks

Test Pricing and Availability

Test Name Regular Price Discount Price
SPTAN1 Gene Early Infantile Epileptic Encephalopathy Type 5 NGS Genetic DNA Test $700 USD $500 USD

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified genetic counselors and neurological specialists ensures comprehensive care regardless of your location.

Take the Next Step Toward Answers

If your child is experiencing symptoms suggestive of early infantile epileptic encephalopathy, don’t delay in seeking definitive answers. Our specialized genetic testing provides the clarity needed to guide appropriate medical management and support services. Contact our genetic counseling team today to schedule your appointment and begin the journey toward understanding your child’s neurological condition.

Call or WhatsApp our genetic specialists today at +1(267) 388-9828 to book your SPTAN1 genetic test and take the first step toward accurate diagnosis and personalized care.